Sinopharm Holding GuoDa Drug Store Co., Ltd.
Sinopharm Holding GuoDa Drug Store Co., Ltd., commonly referred to as GuoDa, is a leading player in the pharmaceutical retail industry, headquartered in China. Established in 2000, the company has rapidly expanded its operations across major regions, including urban centres and rural areas, providing accessible healthcare solutions to millions. GuoDa specialises in the distribution of prescription medications, over-the-counter drugs, and health products, distinguished by its commitment to quality and customer service. The company has achieved significant milestones, including a vast network of retail outlets and a strong online presence, positioning itself as a trusted name in the market. With a focus on innovation and community health, GuoDa continues to enhance its product offerings, ensuring that it meets the evolving needs of consumers. Its notable achievements in the industry underscore its role as a key contributor to China's healthcare landscape.
DitchCarbon Score
How does Sinopharm Holding GuoDa Drug Store Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sinopharm Holding GuoDa Drug Store Co., Ltd.'s score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sinopharm Holding GuoDa Drug Store Co., Ltd., headquartered in China (CN), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Sinopharm Group Co. Ltd., which may influence its climate commitments and performance metrics. As of now, there are no documented reduction targets or climate pledges from Sinopharm Holding GuoDa Drug Store Co., Ltd. However, emissions data and performance metrics may be inherited from its parent company, Sinopharm Group Co. Ltd., which operates at a cascade level of 1. This means that any climate initiatives or emissions reductions may be aligned with the broader strategies of the parent organisation. In the context of the pharmaceutical retail industry, companies are increasingly focusing on sustainability and carbon footprint reduction. While specific initiatives or targets for Sinopharm Holding GuoDa Drug Store Co., Ltd. are not detailed, the industry trend suggests a growing commitment to addressing climate change and reducing greenhouse gas emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|
| Scope 1 | 30,741,540 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 88,611,470 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sinopharm Holding GuoDa Drug Store Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
